Prot# GFT505-315-1: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Elafibranor in Patients with Nonalcoholic Steatohepatitis (NASH) and fibrosis.

  • Rinella, Mary Eugenia (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date9/28/16 → 9/28/21

Funding

  • Covance Inc. (Prot# GFT505-315-1 // Prot# GFT505-315-1)
  • Genfit SA (Prot# GFT505-315-1 // Prot# GFT505-315-1)